204 related articles for article (PubMed ID: 22759465)
1. Alveolar macrophage cathelicidin deficiency in severe sarcoidosis.
Barna BP; Culver DA; Kanchwala A; Singh RJ; Huizar I; Abraham S; Malur A; Marshall I; Kavuru MS; Thomassen MJ
J Innate Immun; 2012; 4(5-6):569-78. PubMed ID: 22759465
[TBL] [Abstract][Full Text] [Related]
2. Cathelicidin as a link between sarcoidosis and tuberculosis.
Korucu E; Pur Ozyigit L; Ortakoylu MG; Bahadir A; Akalin ES; Kara A; Uzun H; Onal B; Caglar E
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Sep; 32(3):222-7. PubMed ID: 26422567
[TBL] [Abstract][Full Text] [Related]
3. Depressed peroxisome proliferator-activated receptor gamma (PPargamma) is indicative of severe pulmonary sarcoidosis: possible involvement of interferon gamma (IFN-gamma).
Barna BP; Culver DA; Abraham S; Malur A; Bonfield TL; John N; Farver CF; Drazba JA; Raychaudhuri B; Kavuru MS; Thomassen MJ
Sarcoidosis Vasc Diffuse Lung Dis; 2006 Jun; 23(2):93-100. PubMed ID: 17937104
[TBL] [Abstract][Full Text] [Related]
4. Cathelicidin augments VDR-dependent anti-leishmanial immune response in Indian Post-Kala-Azar Dermal Leishmaniasis.
Das S; Sardar AH; Abhishek K; Kumar A; Rabidas VN; Das P
Int Immunopharmacol; 2017 Sep; 50():130-138. PubMed ID: 28662432
[TBL] [Abstract][Full Text] [Related]
5. Inter-relationship between tumour necrosis factor-alpha (TNF-alpha) and TNF soluble receptors in pulmonary sarcoidosis.
Armstrong L; Foley NM; Millar AB
Thorax; 1999 Jun; 54(6):524-30. PubMed ID: 10335007
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of tumor necrosis factor-alpha, interleukin-6, platelet-derived growth factor-B and granulocyte-macrophage colony-stimulating factor mRNA in cells of bronchoalveolar lavage fluids from patients with sarcoidosis.
Ishioka S; Saito T; Hiyama K; Haruta Y; Maeda A; Hozawa S; Inamizu T; Yamakido M
Sarcoidosis Vasc Diffuse Lung Dis; 1996 Sep; 13(2):139-45. PubMed ID: 8893383
[TBL] [Abstract][Full Text] [Related]
7. Exaggerated TNFalpha release of alveolar macrophages in corticosteroid resistant sarcoidosis.
Ziegenhagen MW; Rothe ME; Zissel G; Müller-Quernheim J
Sarcoidosis Vasc Diffuse Lung Dis; 2002 Oct; 19(3):185-90. PubMed ID: 12405487
[TBL] [Abstract][Full Text] [Related]
8. [Bronchoalveolar lavage in sarcoidosis].
Sato S
Nihon Rinsho; 2002 Sep; 60(9):1766-71. PubMed ID: 12233073
[TBL] [Abstract][Full Text] [Related]
9. Cathelicidin LL-37 in bronchoalveolar lavage and epithelial lining fluids from healthy individuals and sarcoidosis patients.
Golec M; Reichel C; Lemieszek M; Buczkowski J; Mackiewicz B; Skórska C; Dutkiewicz J; Góra A; Ziesche R; Milanowski J
J Biol Regul Homeost Agents; 2014; 28(1):73-9. PubMed ID: 24750793
[TBL] [Abstract][Full Text] [Related]
10. Correlation between 25-hydroxyvitamin D3 1 alpha-hydroxylase gene expression in alveolar macrophages and the activity of sarcoidosis.
Inui N; Murayama A; Sasaki S; Suda T; Chida K; Kato S; Nakamura H
Am J Med; 2001 Jun; 110(9):687-93. PubMed ID: 11403752
[TBL] [Abstract][Full Text] [Related]
11. No evidence of altered alveolar macrophage polarization, but reduced expression of TLR2, in bronchoalveolar lavage cells in sarcoidosis.
Wikén M; Idali F; Al Hayja MA; Grunewald J; Eklund A; Wahlström J
Respir Res; 2010 Sep; 11(1):121. PubMed ID: 20813038
[TBL] [Abstract][Full Text] [Related]
12. Increased interleukin-13 expression in patients with sarcoidosis.
Hauber HP; Gholami D; Meyer A; Pforte A
Thorax; 2003 Jun; 58(6):519-24. PubMed ID: 12775866
[TBL] [Abstract][Full Text] [Related]
13. Carbon nanotube-induced pulmonary granulomatous disease: Twist1 and alveolar macrophage M1 activation.
Barna BP; Huizar I; Malur A; McPeek M; Marshall I; Jacob M; Dobbs L; Kavuru MS; Thomassen MJ
Int J Mol Sci; 2013 Dec; 14(12):23858-71. PubMed ID: 24322444
[TBL] [Abstract][Full Text] [Related]
14. Shed soluble ICAM-1 molecules in bronchoalveolar lavage cell supernatants and serum of patients with pulmonary sarcoidosis.
Bäumer I; Zissel G; Schlaak M; Müller-Quernheim J
Lung; 1997; 175(2):105-16. PubMed ID: 9042667
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D, Cathelicidin, Prolactin, Autoantibodies, and Cytokines in Different Forms of Pulmonary Tuberculosis versus Sarcoidosis.
Vasilyevna Belyaeva I; Pavlovitch Churilov L; Robertovnа Mikhailova L; Vladimirovitch Nikolaev A; Andreevna Starshinova A; Kazimirovitch Yablonsky P
Isr Med Assoc J; 2017 Aug; 19(8):499-505. PubMed ID: 28825769
[TBL] [Abstract][Full Text] [Related]
16. Alveolar macrophage TNF-alpha release and BAL cell phenotypes in sarcoidosis.
Zheng L; Teschler H; Guzman J; Hübner K; Striz I; Costabel U
Am J Respir Crit Care Med; 1995 Sep; 152(3):1061-6. PubMed ID: 7663784
[TBL] [Abstract][Full Text] [Related]
17. Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factor-alpha and interleukin-6 but not interleukin-1 beta.
Bost TW; Riches DW; Schumacher B; Carré PC; Khan TZ; Martinez JA; Newman LS
Am J Respir Cell Mol Biol; 1994 May; 10(5):506-13. PubMed ID: 8179912
[TBL] [Abstract][Full Text] [Related]
18. Histone acetylation in keratinocytes enables control of the expression of cathelicidin and CD14 by 1,25-dihydroxyvitamin D3.
Schauber J; Oda Y; Büchau AS; Yun QC; Steinmeyer A; Zügel U; Bikle DD; Gallo RL
J Invest Dermatol; 2008 Apr; 128(4):816-24. PubMed ID: 17943182
[TBL] [Abstract][Full Text] [Related]
19. 1,25-dihydroxycholecalciferol stimulates ICAM-1 expression of human alveolar macrophages in healthy controls and patients with sarcoidosis.
Braun J; Dinkelacker C; Bohnet S; Kreft B; Dalhoff K
Lung; 1999; 177(3):139-49. PubMed ID: 10192761
[TBL] [Abstract][Full Text] [Related]
20. Increased spontaneous interleukin-10 release from alveolar macrophages in active pulmonary sarcoidosis.
Oltmanns U; Schmidt B; Hoernig S; Witt C; John M
Exp Lung Res; 2003 Jul; 29(5):315-28. PubMed ID: 12746045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
